Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Registration for Sidoti's 2020 Fall Virtual Investor Conference is Now Open
02:00pm, Thursday, 30'th Jul 2020
Our Biannual Investor Conference has become a leading forum for small-cap companies to interface with investors specifically interested in the small-cap equities.
The
Dyadic International Announces Fully Funded Human Health R&D Collaboration with a Top Five Pharmaceutical Company | | IT Business Net
03:15pm, Wednesday, 15'th Jul 2020
JUPITER, FL / ACCESSWIRE / July 15, 2020 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechn
Dyadic International Announces Fully Funded Human Health R&D Collaboration with a Top Five Pharmaceutical Company
12:30pm, Wednesday, 15'th Jul 2020
JUPITER, FL / ACCESSWIRE / July 15, 2020 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (DYAI), a global biotechnology company focused on further improving and applying i
DYAI: Dyadic Animal Health Partners Summary
12:06pm, Friday, 10'th Jul 2020
By John Vandermosten, CFA NASDAQ:DYAI On July 8, 2020, Dyadic (NASDAQ:DYAI) announced the successful addition of two, fully funded collaborations with global animal health companies to study whether i
Dyadic Announces Two New Fully Funded Collaborations with Leading Global Animal Health Companies
12:30pm, Wednesday, 08'th Jul 2020
JUPITER, FL / ACCESSWIRE / July 8, 2020 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (DYAI), a global biotechnology company focused on further improving and applying it
DYADIC INTERNATIONAL INC : Submission of Matters to a Vote of Security Holders (form 8-K) | MarketScreener
09:05pm, Wednesday, 01'st Jul 2020Dyadic International (NASDAQ:DYAI) Given Buy Rating at Noble Financial
04:00am, Tuesday, 30'th Jun 2020
Noble Financial reaffirmed their buy rating on shares of Dyadic International (NASDAQ:DYAI) in a research note published on Monday, TipRanks reports. Noble Financial currently has a $11.00 price objec
Dyadic International (DYAI) Receives a Buy from Noble Financial - Markets
08:06pm, Monday, 29'th Jun 2020
Noble Financial analyst Ahu Demir reiterated a Buy rating on Dyadic International (DYAI – Research Report) today and set a
Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index | | IT Business Net
12:12pm, Monday, 29'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 29, 2020 / Dyadic International, Inc. ("Dyadic") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 ge
Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index
12:00pm, Monday, 29'th Jun 2020
JUPITER, FL / ACCESSWIRE / June 29, 2020 / Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression pla
This Revolutionary Biotech Is Shrouded in Mystery. Is It a Buy? | The Motley Fool
10:23am, Wednesday, 24'th Jun 2020
This small-cap stock is developing a technology that could revolutionize biotech.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Noble Financial Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
11:56am, Monday, 15'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
